» Articles » PMID: 38867262

Comprehensive Transcriptomic Analysis Unveils Macrophage-associated Genes for Establishing an Abdominal Aortic Aneurysm Diagnostic Model and Molecular Therapeutic Framework

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2024 Jun 12
PMID 38867262
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Abdominal aortic aneurysm (AAA) is a highly lethal cardiovascular disease. The aim of this research is to identify new biomarkers and therapeutic targets for the treatment of such deadly diseases.

Methods: Single-sample gene set enrichment analysis (ssGSEA) and CIBERSORT algorithms were used to identify distinct immune cell infiltration types between AAA and normal abdominal aortas. Single-cell RNA sequencing data were used to analyse the hallmark genes of AAA-associated macrophage cell subsets. Six macrophage-related hub genes were identified through weighted gene co-expression network analysis (WGCNA) and validated for expression in clinical samples and AAA mouse models. We screened potential therapeutic drugs for AAA through online Connectivity Map databases (CMap). A network-based approach was used to explore the relationships between the candidate genes and transcription factors (TFs), lncRNAs, and miRNAs. Additionally, we also identified hub genes that can effectively identify AAA and atherosclerosis (AS) through a variety of machine learning algorithms.

Results: We obtained six macrophage hub genes (IL-1B, CXCL1, SOCS3, SLC2A3, G0S2, and CCL3) that can effectively diagnose abdominal aortic aneurysm. The ROC curves and decision curve analysis (DCA) were combined to further confirm the good diagnostic efficacy of the hub genes. Further analysis revealed that the expression of the six hub genes mentioned above was significantly increased in AAA patients and mice. We also constructed TF regulatory networks and competing endogenous RNA networks (ceRNA) to reveal potential mechanisms of disease occurrence. We also obtained two key genes (ZNF652 and UBR5) through a variety of machine learning algorithms, which can effectively distinguish abdominal aortic aneurysm and atherosclerosis.

Conclusion: Our findings depict the molecular pharmaceutical network in AAA, providing new ideas for effective diagnosis and treatment of diseases.

References
1.
Xu Z, Lang D, Wang D, Hu S, Yang L . LncRNA FGD5-AS1 Promotes Abdominal Aortic Aneurysm Growth Through the Activation of MMP3 in Vascular Smooth Muscle Cells. Int Heart J. 2023; 64(3):470-482. DOI: 10.1536/ihj.22-106. View

2.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

3.
Lu G, Su G, Davis J, Schaheen B, Downs E, Roy R . A novel chronic advanced stage abdominal aortic aneurysm murine model. J Vasc Surg. 2017; 66(1):232-242.e4. PMC: 5483384. DOI: 10.1016/j.jvs.2016.07.105. View

4.
Davis F, Tsoi L, Melvin W, DenDekker A, Wasikowski R, Joshi A . Inhibition of macrophage histone demethylase JMJD3 protects against abdominal aortic aneurysms. J Exp Med. 2021; 218(6). PMC: 8008365. DOI: 10.1084/jem.20201839. View

5.
Huang Z, Tong Y, Tian H, Zhao C . Establishment of a Prognostic Nomogram for Lung Adenocarcinoma with Brain Metastases. World Neurosurg. 2020; 141:e700-e709. DOI: 10.1016/j.wneu.2020.05.273. View